Screener
AbCellera Biologics Inc. ABCL Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
Based on the most recent quarter.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
FAQ
- What is AbCellera Biologics Inc.'s current ratio?
- AbCellera Biologics Inc. (ABCL) reported current ratio of 12.8× in Q2 2026.
- How has AbCellera Biologics Inc.'s current ratio changed year-over-year?
- AbCellera Biologics Inc.'s current ratio increased by 15.3% year-over-year, from 11.1× to 12.8×.
- What is the long-term trend for AbCellera Biologics Inc.'s current ratio?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s current ratio has grown at a 7.6% compound annual growth rate (CAGR), from 7.9× to 11.3×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about AbCellera Biologics Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude